HIV Medicine Manufacturer
Affordable Treatment: Not Letting HIV Define You
HIV is no longer a terminal disease; it is a treatable and manageable condition.
At Aprazer Healthcare, we are committed to ending the HIV epidemic by continuously developing innovative treatments and making them available at the lowest rates.
The Global Access Crisis
Every year, millions of people die of AIDS because of lack of access to essential life‑saving medications. 95% of these belong to low‑income groups that cannot afford treatment or reside in low‑income countries without basic healthcare amenities.
Challenges in HIV/AIDS Treatment
- ✔ High treatment costs: Anti‑retroviral therapy is lifelong and constitutes an expensive treatment that most people cannot afford.
- ✔ Limited access: Geographical barriers and poor healthcare facilities and services.
- ✔ Fear of Social Discrimination: Social taboos prevent treatment, prevention, or testing.
- ✔ In compliance to treatment: Missed doses and incomplete treatments cause failures and increase infection risk.
- ✔ Disrupted Global supply chain: Shortages of HIV therapeutics in low‑income countries.
- ✔ Other infections: Opportunistic infections invade the weakened immune system.
Aprazer Healthcare: Making a Global Impact through Access to Affordable Medicine
From India to Africa, Aprazer Healthcare is transforming global access to WHO pre‑qualified ARV medicines at affordable rates. Through strong distribution and collaboration with partners, organizations, and hospitals, we ensure reach to even the most remote areas.
Our Product Portfolio
Advancing HIV Treatment with Combined Drug Formulations for the ART Regimen:
Abakast‑L (Abacavir & Lamivudine – NRTI combination)
Lamipure‑150 (Lamivudine – NRT inhibitor for HIV & Hepatitis B)
Lopikast (Lopinavir & Ritonavir combination)
Temirazor (Tenofovir disoproxil fumarate & emtricitabine)
Tudobest‑L (Tenofovir Disoproxil Fumarate & Lamivudine)
Tudobest‑LE (Tenofovir Disoproxil Fumarate, Efavirenz & Lamivudine)
Virarazer (Tenofovir Disoproxil Fumarate, Emtricitabine & Efavirenz)
We aim to continually reduce the cost of manufacturing and streamline our distribution network to make life‑saving medicines accessible to all, wherever they are.
"Building a sustainable future for generations to come."
FAQ
What is HIV?
HIV is an infection of the immune system, weakening the body’s defense mechanisms.
What are the HIV symptoms?
• Swelling of the lymph nodes
• Extreme weakness
• Persistent fever
When does HIV transform into AIDS?
AIDS is the advanced or last stage of HIV, where the body severely loses immunity, catching various infections such as tuberculosis, candidiasis, and Pneumocystis pneumonia.
What are HIV medicines?
• Abakast‑L – Abacavir & Lamivudine
• Lamipure‑150 – Lamivudine
• Lopikast – Lopinavir and Ritonavir
• Virarazer – Tenofovir Disoproxil Fumarate, Emtricitabine & Efavirenz
• Tudobest‑LE – Tenofovir Disoproxil Fumarate, Efavirenz & Lamivudine
• Tudobest‑L – Tenofovir Disoproxil Fumarate & Lamivudine
What is HIV fixed‑dose combination therapy?
A fixed‑dose drug combination is used as a single‑dose pill and offers potential viral suppression.
• Virarazer
• Tudobest‑LE
• Tudobest‑L
What is the working of HIV medicines?
HIV medicines work by disrupting the virus's cell cycle, inhibiting replication and multiplication.
What are HIV medicine side effects?
• Nausea
• Vomiting
• Skin rashes
• Headache
• Dizziness
• Weakness
• Sleep disturbances
• Diarrhea
Which medicine protects from HIV?
Temirazer – widely used for pre‑exposure prophylaxis (PrEP).
How long does HIV treatment last?
HIV treatment is lifelong. It does not eliminate the virus but inhibits replication and multiplication.
Which is the largest HIV medicine manufacturer?
Aprazer stands as the leading HIV medicine manufacturer, developing world‑standard, premium‑quality HIV medicines.
• WHO‑GMP‑certified medicines
• Assured quality and efficacy
• 300+ generic HIV medicines
Which is the largest HIV medicine exporter?
Aprazer Healthcare is the leading HIV medicine exporter to 50+ countries, supplying to leading hospitals, medical centers, government institutes, and NGO healthcare programs.
